medmix AG reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CHF 248.1 million compared to CHF 250.6 million a year ago. Net income was CHF 7.3 million compared to CHF 9.2 million a year ago.

Basic earnings per share from continuing operations was CHF 0.18 compared to CHF 0.23 a year ago. Diluted earnings per share from continuing operations was CHF 0.18 compared to CHF 0.22 a year ago.